Diseases, Conditions, Syndromes

New understanding of TB could lead to personalised treatments

Tuberculosis (TB) used to kill one in seven people around the world before the advent of antibiotics. However the increasing prevalence of multi-drug resistant TB means that doctors are running out of options in trying to ...

Oncology & Cancer

Tuning macrophages a 'breakthrough' in cancer immunotherapy

Similar to stem cells differentiating to make your body's tissues, the immune system's macrophages pick a life path, differentiating into macrophages that recruit resources for wound repair or macrophages that recruit resources ...

Medical research

FDA-approved drug protects mice from Ebola

The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there ...

Inflammatory disorders

Severe asthma fails to respond to mainstay treatment

The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those ...

Medical research

New infections cause dormant viruses to reactivate

The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes ...

Oncology & Cancer

Potential lung cancer vaccine shows renewed promise

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. ...

Medical research

How invariant natural killers keep tuberculosis in check

Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe. Most healthy people can defend themselves against tuberculosis, but they need all parts of their immune system to work together. A study ...

Oncology & Cancer

Study reveals trigger that may speed melanoma growth

(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.

page 3 from 4